405 related articles for article (PubMed ID: 14972658)
1. Cholecystokinin modulation of locomotor behavior in rats is sensitized by chronic amphetamine and chronic restraint stress exposure.
Wunderlich GR; Rotzinger S; Bush DE; DeSousa NJ; Vaccarino FJ
Brain Res; 2004 Mar; 1001(1-2):95-107. PubMed ID: 14972658
[TBL] [Abstract][Full Text] [Related]
2. Necessary role for ventral tegmental area adenylate cyclase and protein kinase A in induction of behavioral sensitization to intraventral tegmental area amphetamine.
Tolliver BK; Ho LB; Fox LM; Berger SP
J Pharmacol Exp Ther; 1999 Apr; 289(1):38-47. PubMed ID: 10086985
[TBL] [Abstract][Full Text] [Related]
3. Amphetamine-induced neurochemical and locomotor responses are expressed differentially across the anteroposterior axis of the core and shell subterritories of the nucleus accumbens.
Heidbreder C; Feldon J
Synapse; 1998 Aug; 29(4):310-22. PubMed ID: 9661249
[TBL] [Abstract][Full Text] [Related]
4. A single social defeat induces short-lasting behavioral sensitization to amphetamine.
de Jong JG; Wasilewski M; van der Vegt BJ; Buwalda B; Koolhaas JM
Physiol Behav; 2005 Jan; 83(5):805-11. PubMed ID: 15639166
[TBL] [Abstract][Full Text] [Related]
5. Cholecystokinin modulates both the development and the expression of behavioral sensitization to amphetamine in the rat.
Wunderlich GR; DeSousa NJ; Vaccarino FJ
Psychopharmacology (Berl); 2000 Aug; 151(2-3):283-90. PubMed ID: 10972475
[TBL] [Abstract][Full Text] [Related]
6. Differentially altered mGluR1 and mGluR5 mRNA expression in rat caudate nucleus and nucleus accumbens in the development and expression of behavioral sensitization to repeated amphetamine administration.
Mao L; Wang JQ
Synapse; 2001 Sep; 41(3):230-40. PubMed ID: 11418936
[TBL] [Abstract][Full Text] [Related]
7. Nucleus accumbens cholecystokinin (CCK) can either attenuate or potentiate amphetamine-induced locomotor activity: evidence for rostral-caudal differences in accumbens CCK function.
Vaccarino FJ; Rankin J
Behav Neurosci; 1989 Aug; 103(4):831-6. PubMed ID: 2765186
[TBL] [Abstract][Full Text] [Related]
8. Blockade of group II, but not group I, mGluRs in the rat nucleus accumbens inhibits the expression of conditioned hyperactivity in an amphetamine-associated environment.
Kim WY; Vezina P; Kim JH
Behav Brain Res; 2008 Aug; 191(1):62-6. PubMed ID: 18433894
[TBL] [Abstract][Full Text] [Related]
9. Chronic microinjection of valproic acid into the nucleus accumbens attenuates amphetamine-induced locomotor activity.
Kim WY; Kim S; Kim JH
Neurosci Lett; 2008 Feb; 432(1):54-7. PubMed ID: 18164815
[TBL] [Abstract][Full Text] [Related]
10. Amphetamine withdrawal leads to behavioral sensitization and reduced HPA axis response following amphetamine challenge.
Russig H; Pryce CR; Feldon J
Brain Res; 2006 Apr; 1084(1):185-95. PubMed ID: 16563358
[TBL] [Abstract][Full Text] [Related]
11. A glutamate-dopamine interaction in the persistent enhanced response to amphetamine in nucleus accumbens core but not shell following a single restraint stress.
Pacchioni AM; Cador M; Bregonzio C; Cancela LM
Neuropsychopharmacology; 2007 Mar; 32(3):682-92. PubMed ID: 16641941
[TBL] [Abstract][Full Text] [Related]
12. Amphetamine and stress responses in developmentally lead-exposed rats.
Virgolini MB; Volosin M; Fulginiti AS; Cancela LM
Neurotoxicol Teratol; 2004; 26(2):291-303. PubMed ID: 15019963
[TBL] [Abstract][Full Text] [Related]
13. Differential activation of dopamine release in the nucleus accumbens core and shell after acute or repeated amphetamine injections: a comparative study in the Roman high- and low-avoidance rat lines.
Giorgi O; Piras G; Lecca D; Corda MG
Neuroscience; 2005; 135(3):987-98. PubMed ID: 16154292
[TBL] [Abstract][Full Text] [Related]
14. Differential involvement of ventral tegmental GABA(A) and GABA(B) receptors in the regulation of the nucleus accumbens dopamine response to stress.
Doherty M; Gratton A
Brain Res; 2007 May; 1150():62-8. PubMed ID: 17395162
[TBL] [Abstract][Full Text] [Related]
15. Netrin-1 receptor in the ventral tegmental area is required for sensitization to amphetamine.
Yetnikoff L; Eng C; Benning S; Flores C
Eur J Neurosci; 2010 Apr; 31(7):1292-302. PubMed ID: 20345916
[TBL] [Abstract][Full Text] [Related]
16. Involvement of 5-HT1B receptors within the ventral tegmental area in ethanol-induced increases in mesolimbic dopaminergic transmission.
Yan QS; Zheng SZ; Feng MJ; Yan SE
Brain Res; 2005 Oct; 1060(1-2):126-37. PubMed ID: 16212943
[TBL] [Abstract][Full Text] [Related]
17. Subtype-selective cholecystokinin receptor antagonists block cholecystokinin modulation of dopamine-mediated behaviors in the rat mesolimbic pathway.
Crawley JN
J Neurosci; 1992 Sep; 12(9):3380-91. PubMed ID: 1527584
[TBL] [Abstract][Full Text] [Related]
18. Maternal immune activation in late gestation enhances locomotor response to acute but not chronic amphetamine treatment in male mice offspring: role of the D1 receptor.
Zager A; Mennecier G; Palermo-Neto J
Behav Brain Res; 2012 Jun; 232(1):30-6. PubMed ID: 22487249
[TBL] [Abstract][Full Text] [Related]
19. Sensitization of midbrain dopamine neuron reactivity and the self-administration of psychomotor stimulant drugs.
Vezina P
Neurosci Biobehav Rev; 2004 Jan; 27(8):827-39. PubMed ID: 15019432
[TBL] [Abstract][Full Text] [Related]
20. Nitrous oxide and xenon prevent amphetamine-induced carrier-mediated dopamine release in a memantine-like fashion and protect against behavioral sensitization.
David HN; Ansseau M; Lemaire M; Abraini JH
Biol Psychiatry; 2006 Jul; 60(1):49-57. PubMed ID: 16427030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
